FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

1808111000001100: Retalzem 60 modified-release tablets (Kent Pharma (UK) Ltd) 100 tablet 4 x 25 tablets (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1895101000001110 Retalzem 60 modified-release tablets (Kent Pharma (UK) Ltd) 100 tablet 4 x 25 tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1895121000001115 Retalzem 60 modified-release tablets (Kent Pharma (UK) Ltd) 100 tablet 4 x 25 tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Retalzem 60 modified-release tablets (Kent Pharma (UK) Ltd) 100 tablet 4 x 25 tablets Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Retalzem 60 modified-release tablets (Kent Pharma (UK) Ltd) 100 tablet 4 x 25 tablets Is a Diltiazem 60mg modified-release tablets 100 tablet true Inferred relationship Existential restriction modifier
Retalzem 60 modified-release tablets (Kent Pharma (UK) Ltd) 100 tablet 4 x 25 tablets Is pack of Retalzem 60 modified-release tablets (Kent Pharma (UK) Ltd) false Inferred relationship Existential restriction modifier
Retalzem 60 modified-release tablets (Kent Pharma (UK) Ltd) 100 tablet 4 x 25 tablets Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Retalzem 60 modified-release tablets (Kent Pharma (UK) Ltd) 100 tablet 4 x 25 tablets Has active ingredient Diltiazem hydrochloride false Inferred relationship Existential restriction modifier
Retalzem 60 modified-release tablets (Kent Pharma (UK) Ltd) 100 tablet 4 x 25 tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Retalzem 60 modified-release tablets (Kent Pharma (UK) Ltd) 100 tablet 4 x 25 tablets VMP prescribing status (attribute) Caution - AMP level prescribing advised true Inferred relationship Existential restriction modifier
Retalzem 60 modified-release tablets (Kent Pharma (UK) Ltd) 100 tablet 4 x 25 tablets Has excipient Lactose false Inferred relationship Existential restriction modifier
Retalzem 60 modified-release tablets (Kent Pharma (UK) Ltd) 100 tablet 4 x 25 tablets Discontinued indicator Re-marketed false Inferred relationship Existential restriction modifier
Retalzem 60 modified-release tablets (Kent Pharma (UK) Ltd) 100 tablet 4 x 25 tablets Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Retalzem 60 modified-release tablets (Kent Pharma (UK) Ltd) 100 tablet 4 x 25 tablets VMP prescribing status (attribute) VMP valid as a prescribable product false Inferred relationship Existential restriction modifier
Retalzem 60 modified-release tablets (Kent Pharma (UK) Ltd) 100 tablet 4 x 25 tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Retalzem 60 modified-release tablets (Kent Pharma (UK) Ltd) 100 tablet 4 x 25 tablets Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Retalzem 60 modified-release tablets (Kent Pharma (UK) Ltd) 100 tablet 4 x 25 tablets Has AMP Retalzem 60 modified-release tablets (Kent Pharma (UK) Ltd) true Inferred relationship Existential restriction modifier
Retalzem 60 modified-release tablets (Kent Pharma (UK) Ltd) 100 tablet 4 x 25 tablets Has specific active ingredient Diltiazem hydrochloride true Inferred relationship Existential restriction modifier
Retalzem 60 modified-release tablets (Kent Pharma (UK) Ltd) 100 tablet 4 x 25 tablets Has dispensed dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Retalzem 60 modified-release tablets (Kent Pharma (UK) Ltd) 100 tablet 4 x 25 tablets Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Retalzem 60 modified-release tablets (Kent Pharma (UK) Ltd) 100 tablet 4 x 25 tablets Discontinued indicator Discontinued AMPP(qualifier value) false Inferred relationship Existential restriction modifier
Retalzem 60 modified-release tablets (Kent Pharma (UK) Ltd) 100 tablet 4 x 25 tablets Discontinued indicator Re-marketed false Inferred relationship Existential restriction modifier
Retalzem 60 modified-release tablets (Kent Pharma (UK) Ltd) 100 tablet 4 x 25 tablets Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Retalzem 60 modified-release tablets (Kent Pharma (UK) Ltd) 100 tablet 4 x 25 tablets VMP prescribing status (attribute) VMP not recommended to prescribe - brands not bioequivalent false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start